European Journal of Cardiovascular Medicine

Imatinib is used in treatment of CML with Philadelphia chromosome positivity. Hepatotoxicity grade1-4 is described in literature. There is a case report of imatinib induced iron overload in a 46 year old male after 8 months of treatment with imatinib which is to our knowledge the only  in this regard. We report case of a 60 year old man who was on treatment for BCR-ABL positive CML for past 10 years now presenting with features of hepatic hemosiderosis. After ruling out known congenital and acquired causes the case can be attributed to Imatinib therapy.